Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.

Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, Helman E, Radke MR, Say C, Vo LT, Mann E, Isaacson JD, Maloney L, O'Malley DM, Chambers SK, Kaufmann SH, Scott CL, Konecny GE, Coleman RL, Sun JX, Giordano H, Brenton JD, Harding TC, McNeish IA, Swisher EM.

Cancer Discov. 2019 Feb;9(2):210-219. doi: 10.1158/2159-8290.CD-18-0715. Epub 2018 Nov 13.

PMID:
30425037
2.

Assessment of net lending strategy to better reach mobile and migrant populations in malaria endemic areas of Cambodia.

Lek D, Gopinath D, Ek S, Heng S, Bun S, Say C, Sokomar N, Ty KS, Rekol H.

Infect Dis Poverty. 2018 Oct 18;7(1):107. doi: 10.1186/s40249-018-0489-1.

3.

Feasibility of optimizing intensity-modulated radiation therapy plans based on measured mucosal dose adjacent to dental fillings and toxicity outcomes.

Seol SW, Aggarwal S, von Eyben R, Wang Z, Chan C, Say C, Xing L, Hara W, Yang Y, Le QT.

J Appl Clin Med Phys. 2018 Sep;19(5):444-452. doi: 10.1002/acm2.12407. Epub 2018 Jul 9.

4.

Deconvoluting the effects of surface chemistry and nanoscale topography: Pseudomonas aeruginosa biofilm nucleation on Si-based substrates.

Zhang J, Huang J, Say C, Dorit RL, Queeney KT.

J Colloid Interface Sci. 2018 Jun 1;519:203-213. doi: 10.1016/j.jcis.2018.02.068. Epub 2018 Feb 24.

PMID:
29500992
5.

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, Dudley JC, Binkley MS, Modlin L, Padda SK, Gensheimer MF, West RB, Shrager JB, Neal JW, Wakelee HA, Loo BW Jr, Alizadeh AA, Diehn M.

Cancer Discov. 2017 Dec;7(12):1394-1403. doi: 10.1158/2159-8290.CD-17-0716. Epub 2017 Sep 24.

6.

Molecular profiling of single circulating tumor cells from lung cancer patients.

Park SM, Wong DJ, Ooi CC, Kurtz DM, Vermesh O, Aalipour A, Suh S, Pian KL, Chabon JJ, Lee SH, Jamali M, Say C, Carter JN, Lee LP, Kuschner WG, Schwartz EJ, Shrager JB, Neal JW, Wakelee HA, Diehn M, Nair VS, Wang SX, Gambhir SS.

Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):E8379-E8386. doi: 10.1073/pnas.1608461113. Epub 2016 Dec 12.

7.

Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.

Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, Heiser D, Zhou L, Say C, Carter JN, Hiniker SM, Loo BW Jr, West RB, Beachy P, Alizadeh AA, Diehn M.

Cancer Discov. 2017 Jan;7(1):86-101. doi: 10.1158/2159-8290.CD-16-0127. Epub 2016 Sep 23.

8.

Integrated digital error suppression for improved detection of circulating tumor DNA.

Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, Loo BW Jr, Neal JW, Wakelee HA, Diehn M, Alizadeh AA.

Nat Biotechnol. 2016 May;34(5):547-555. doi: 10.1038/nbt.3520. Epub 2016 Mar 28.

9.

Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.

Kuo P, Bratman SV, Shultz DB, von Eyben R, Chan C, Wang Z, Say C, Gupta A, Loo BW Jr, Giaccia AJ, Koong AC, Diehn M, Le QT.

Clin Cancer Res. 2014 Nov 1;20(21):5558-69. doi: 10.1158/1078-0432.CCR-14-1138. Epub 2014 Sep 4.

10.

Treatment of hypertension in rural Cambodia: results from a 6-year programme.

Isaakidis P, Raguenaud ME, Say C, De Clerck H, Khim C, Pottier R, Kuoch S, Prahors U, Chour S, Van Damme W, Reid T.

J Hum Hypertens. 2011 Apr;25(4):241-9. doi: 10.1038/jhh.2010.49. Epub 2010 May 6.

PMID:
20445572
11.

Quantification of two basic proteins related to a thymic hormone (LSH) and their occurrence in serum of normal and cancerous adults.

Luckey TD, Venugopal B, LeGrand R, Militzer E, Say C.

Cancer Biochem Biophys. 1976 Aug;1(5):223-8.

PMID:
975024
12.

Prognostic factors in Hodgkin's disease.

Say C, Lee YT, Hori J, Spratt JS Jr.

J Surg Oncol. 1975;7(4):255-67.

PMID:
1177460
13.

Transitional cell carcinoma of the renal pelvis: experience from 1940 to 1972 and literature review.

Say CC, Hori JM.

J Urol. 1974 Oct;112(4):438-42. No abstract available.

PMID:
4416700
14.

Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes.

Say CC, Donegan WL.

Cancer. 1974 Aug;34(2):468-71. No abstract available.

PMID:
4852558
15.

A biostatistical evaluation of complications from mastectomy.

Say CC, Donegan W.

Surg Gynecol Obstet. 1974 Mar;138(3):370-6. No abstract available.

PMID:
4811322
16.

Peripheral lymphocyte counts and prognosis in malignant lymphomas.

Lee YT, Say C, Hori JM.

Mo Med. 1974 Feb;71(2):69-73. No abstract available.

PMID:
4812195
17.

Chemodectoma with distant metastasis: case report and review of the literature.

Say CC, Hori J, Spratt J Jr.

Am Surg. 1973 Jun;39(6):333-41. No abstract available.

PMID:
4350420
18.

Major surgery in Hodgkin's disease and other malignant lymphomas.

Lee YT, Say C, Hori JM, Spratt JS Jr.

J Surg Oncol. 1973 May;5(5):465-74. No abstract available.

PMID:
4752464
19.

Clinical courses of Hodgkin's disease and other malignant lymphomas.

Lee YT, Say C, Hori JM, Spratt JS Jr.

Am J Roentgenol Radium Ther Nucl Med. 1973 Jan;117(1):19-29. No abstract available.

PMID:
4568243

Supplemental Content

Support Center